Cell Signaling Technology

Toll-like Receptor 9 (F4R3J) Rabbit Monoclonal Antibody

#67887 · $161

4
Citing papers
111
Combined citations
Supplier page Find this product

Research areas

Adipose Tissue and Metabolism1Advanced Breast Cancer Therapies1Cancer-related molecular mechanisms research1Cancer-related Molecular Pathways1CAR-T cell therapy research1PARP inhibition in cancer therapy1Retinoids in leukemia and cellular processes1RNA and protein synthesis mechanisms1

Papers citing this product

1
Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models
Oncotarget·2016·70 cit.·DOI
2
RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes
JCI Insight·2021·29 cit.·DOI
3
Ectopic Otoconin 90 expression in triple negative breast cancer cell lines is associated with metastasis functions
PLoS ONE·2019·9 cit.·DOI
4
5-androstene 3β,17α diol induces autophagic cell death of human breast cancer cells and enhances radiation cytotoxicity
journal of cancer therapeutics and research·2012·3 cit.·DOI

Similar products

ProductVendorPricePapers
Toll-like Receptor 9 AntibodyRabbitCell Signaling Technology$317100
Toll-like Receptor 9 (D2C9) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$152100
Toll-like Receptor 9 (D9M9H) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$16175
Toll-like Receptor 9 (F4R3J) Rabbit Monoclonal Antibody — Evidence — PubIndex